Oncolytic virotherapy as immunotherapy

Recognizing immune responses to oncolytic virotherapy opens the way for new combinations.

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2021-12, Vol.374 (6573), p.1325-1326
Main Authors: Melcher, Alan, Harrington, Kevin, Vile, Richard
Format: Article
Language:English
Subjects:
Animals
Antigen (tumor-associated)
Antigens
Antineoplastic Agents, Immunological - therapeutic use
Combined Modality Therapy
Cytotoxicity
Effector cells
Genetic engineering
Humans
Immune system
Immunotherapy
Microenvironments
Neoplasms - immunology
Neoplasms - therapy
Neoplasms - virology
Oncolysis
Oncolytic Virotherapy
Oncolytic Viruses - genetics
Oncolytic Viruses - immunology
Oncolytic Viruses - physiology
Randomized Controlled Trials as Topic
Toxicity
Tumors
Viral infections
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recognizing immune responses to oncolytic virotherapy opens the way for new combinations.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.abk3436